Bicycle Therapeutics PLC banner

Wall St Price Targets

BCYC Price Forecast
Based on 9 analysts

+176% Upside
from $3.69 today

Bicycle Therapeutics PLC (BCYC)’s 12-month stock price forecast through November 2027 has a consensus target of $10.2, implying 176% upside. The forecast is based on price targets from 9 Wall Street analysts.

BCYC Analyst Rating
Based on 9 analysts

avg. 4.11 of 5
Strong buy
4 44%
Buy
2 22%
Hold
3 33%
Sell
0 0%
Strong sell
0 0%

Analysts rate BCYC Buy, with 6 of 9 recommending Buy or Strong buy.

Bicycle Therapeutics PLC Competitors:
Price Targets

Financial Estimates

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is BCYC's stock price target?
Price Target
10.2 USD

According to Wall Street analysts, the average 1-year price target for BCYC is 10.2 USD with a low forecast of 5.05 USD and a high forecast of 14.7 USD.

What is the Revenue forecast for Bicycle Therapeutics PLC?
Projected CAGR
29%

Over the last 8 years, the compound annual growth rate for Revenue has been 56%. The projected CAGR for the next 8 years is 29%.

Back to Top